{"title":"Hematologic Malignancies","description":"\u003cp\u003eDelve into the complexities of hematologic malignancies with this curated collection. Explore the latest research, treatment options, and patient perspectives in these essential resources for healthcare professionals and those affected by blood cancers.\u003c\/p\u003e","products":[{"product_id":"chronic-lymphocytic-leukemia-book-michael-hallek-9783030113919","title":"Chronic Lymphocytic Leukemia","description":"This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapyof T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ GARDNERS","offer_id":49736226701585,"sku":"NGR9783030113919","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/3030113914.jpg?v=1750999029"},{"product_id":"myeloproliferative-disorders-book-jv-melo-9783540345053","title":"Myeloproliferative Disorders","description":"This book contains a series of contributions from internationally renowned academics with special expertise in one or other diseases which collectively are grouped under the heading myeloproliferative disorders. A feature of this book is the speed with which it has been produced - an important factor in this rapidly moving field.","brand":"WoB","offers":[{"title":"US \/ GOOD \/ SBYB","offer_id":50404195467537,"sku":"CIN3540345051G","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/3540345051.jpg?v=1750807206"},{"product_id":"multiple-myeloma-and-other-plasma-cell-neoplasms-book-meletios-a-dimopoulos-9783319255842","title":"Multiple Myeloma and Other Plasma Cell Neoplasms","description":"This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed\/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myelomaand Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.","brand":"WoB","offers":[{"title":"US \/ VERY_GOOD \/ SBYB","offer_id":50452529840401,"sku":"CIN3319255843VG","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/3319255843.jpg?v=1751252628"},{"product_id":"myeloproliferative-disorders-book-jv-melo-9783642421129","title":"Myeloproliferative Disorders","description":"This book contains a series of contributions from internationally renowned academics with special expertise in one or other diseases which collectively are grouped under the heading myeloproliferative disorders. For the editors this term includes Ph-positive chronic myeloid leukemia but also the various Ph-negative variants, some of which provide fascinating insights into the molecular mechanisms of leukemia. There have been many recent developments in understanding the Pathophysiology and a number of therapeutic innovations in this area. One particular merit of this book is the speed with which it has been produced – an important factor in this very rapidly moving field.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52400973676817,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52400974463249,"sku":"NLS9783642421129","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9783642421129.jpg?v=1758753263"},{"product_id":"acute-myeloid-leukemia-book-christoph-rllig-9783030726782","title":"Acute Myeloid Leukemia","description":"This book, written by a team of leading experts, provides a comprehensive overview of acute myeloid leukemia (AML), the most frequent acute leukemia in adults. The opening chapters present current knowledge of epidemiology, etiologic factors, and the pathogenesis and molecular development of AML. Detailed guidance is offered on laboratory and clinical diagnostic workup and disease classification, and the patient- and disease-related factors that determine prognosis and treatment allocation are identified. On the basis of these general considerations, initial treatments in patients considered fit for intensive treatment and in older and co-morbid patients are reviewed, and the available relapse treatment strategies, explained. For all clinical scenarios, the most recent data on the optimal use of newly approved agents in different AML subgroups are presented. Separate chapters address the treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for innovative trial designs are considered.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52452713300241,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52452713758993,"sku":"NLS9783030726782","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9783030726782.jpg?v=1759365638"},{"product_id":"hematologic-malignancies-multiple-myeloma-and-related-plasma-cell-disorders-book-morie-a-gertz-9783642056437","title":"Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders","description":"From the considerable expertise of the Mayo Clinic, this book spans the gamut from multiple myeloma, the most frequent and most serious of the monoclonal gammopathies, to the rarest related disorders. Laboratory evaluation, associations with nonhematologic disorders, monoclonal gammopathies of undetermined significance, the more obscure plasma cell dyscrasias, amyloidosis, other immunoglobulin deposition disorders, Waldenstr÷m macroglobulinemia, and Fanconi anemia are among the topics covered. Particular attention is paid to multiple myeloma: history, pathogenesis, clinical and laboratory diagnosis, modern therapy, and prognosis.","brand":"WoB","offers":[{"title":"- \/ - \/ INTERNAL","offer_id":52480922681617,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ INGRAM","offer_id":52480923861265,"sku":"NLS9783642056437","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9783642056437.jpg?v=1759850957"},{"product_id":"myeloproliferative-neoplasms-book-tiziano-barbui-9783662520277","title":"Myeloproliferative Neoplasms","description":"This book focuses on three of the main categories of myeloproliferative neoplasm: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Relevant laboratory and clinical advances are comprehensively covered, and great emphasis is placed on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic  approaches, the value and limitations of mutation screening for diagnostic and  prognostic purposes, risk stratification in terms of both survival and other  disease complications such as leukemic transformation and thrombosis, and  modern therapeutic strategies, including conventional drugs, allogeneic stem cell  transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52615469826321,"sku":"NLS9783662520277","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ NEW \/ INGRAM","offer_id":52761909526801,"sku":"NIN9783662520277","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9783662520277.jpg?v=1761524171"}],"url":"https:\/\/www.worldofbooks.com\/collections\/hematologic-malignancies-book-series.oembed","provider":"World of Books ","version":"1.0","type":"link"}